AstraZeneca

Statue in Vienna of Heracles battling the hydra
Biotech

The 'diabolical' molecule set to become biotech's next gold rush

Should medicines that lower Lp(a) reach their full potential, they could spark a craze rivaling obesity and even surpass the success of statins.
Darren Incorvaia Apr 9, 2026 8:00am
concept of growth and then decline

Biopharma R&D pipeline shrinks for 1st time in 30 years: report

Apr 3, 2026 8:13am
positive negative up down good bad mixed

AstraZeneca’s Strensiq successor misses ph. 3 rare disease goal

Mar 31, 2026 5:35am
Graphic of a drop of blood made up of small data points and nodes

AstraZeneca in vivo data shows potential, despite patient death

Mar 27, 2026 11:00am
On target clinical trial success bullseye score

AstraZeneca’s COPD hits breathe life into class rocked by flops

Mar 27, 2026 5:58am
AstraZeneca
Favicon Fierce Pharma

AZ to build cell therapy supply hub, R&D center in Shanghai

Mar 19, 2026 10:20am